Haloperidol Richter

Haloperidol Richter is an injectable solution containing the antipsychotic agent haloperidol. The product is supplied in a standard concentration for intramuscular administration and is marketed in the European Union as a prescription‑only medication. As a butyrophenone derivative, it acts as a dopamine D2 receptor antagonist and is used under medical supervision for specific psychiatric conditions. It is intended for use by qualified health professionals in acute care settings.

Haloperidol Richter is indicated for the management of several acute psychiatric conditions where rapid control of symptoms is required.

- Schizophrenia, particularly acute exacerbations - Acute psychotic episodes associated with mood disorders - Manic episodes in bipolar disorder when immediate calming is needed - Severe agitation or aggression that poses a risk to the patient or others

Side effects of haloperidol injectable solution vary in frequency and severity; they are categorized as common or serious.

Common: - Drowsiness or sedation - Extrapyramidal symptoms (e.g., tremor, rigidity) - Dry mouth - Orthostatic hypotension

Serious: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe cardiac arrhythmias - Hyperprolactinemia with galactorrhea

When prescribing Haloperidol Richter, clinicians should consider several precautionary measures to minimize risk.

- Assess cardiovascular status before initiating therapy. - Monitor for signs of extrapyramidal reactions, especially in the first few days. - Use the lowest effective dose for the shortest duration needed. - Evaluate liver and renal function in patients with organ impairment. - Exercise caution in patients with a history of seizures or neuroleptic malignant syndrome.

Haloperidol injectable solution can interact with other medications; some combinations should be avoided while others require careful monitoring.

Avoid: - Other dopamine antagonists or high‑potency antipsychotics - Drugs that prolong the QT interval (e.g., certain antiarrhythmics, macrolide antibiotics) - CNS depressants such as benzodiazepines in high doses

Use with caution: - Anticholinergic agents (may mask extrapyramidal symptoms) - CYP3A4 inhibitors or inducers affecting haloperidol metabolism - Lithium therapy (increased risk of neurotoxicity)